There is an FDA-licensed safe and effective vaccine for anthrax, but it requires six doses over an 18-month time period and an annual booster.
Although groups initially considered for preexposure vaccination for bioterrorism preparedness included emergency first responders, federal responders, medical practitioners, and private citizens, vaccination of these groups is not recommended. However, for the military and other select populations or for groups for which a calculable risk can be assessed, preexposure vaccination may be indicated.
If concern exists that persons entering an area of a previous B. anthracis release might be at risk for exposure from a re-release of a primary aerosol of the organism or exposure from a high concentration of settled spores in a specific area, initiation of prophylaxis should be considered with antibiotics alone or in combination with anthrax vaccine.
Additional information about anthrax is available at the College's Bioterrorism Resource Center.
Search this point-of-care decision support tool today. A free benefit of ACP membership.
Reviews of the World's Top Medical Journals - FREE to ACP Members!
|ACP JournalWiseSM is mobile optimized with optional email alerts! Get access to reviews from over 120 of the world's top medical journals alerting you to the highest quality, most clinically relevant new articles based on your preferred areas of specialty. ACP Members register your FREE account now!|
New CME Option: Internal Medicine 2014 Recordings
New CME Package
|Includes 75 of the most popular sessions in internal medicine and the subspecialties. Stream the sessions, answer brief quizzes and earn CME credit. See details.|